Moleculin Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Moleculin Biotech has a total shareholder equity of $21.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $30.8M and $9.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$16.82m |
| Equity | US$21.59m |
| Total liabilities | US$9.26m |
| Total assets | US$30.85m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MOL's short term assets ($19.0M) exceed its short term liabilities ($5.4M).
Long Term Liabilities: MOL's short term assets ($19.0M) exceed its long term liabilities ($3.9M).
Debt to Equity History and Analysis
Debt Level: MOL is debt free.
Reducing Debt: MOL had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MOL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: MOL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 14.6% each year